Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.690
0.00 (0.00%)
Dec 20, 2024, 4:00 PM EST - Market closed
Anixa Biosciences Employees
As of October 31, 2023, Anixa Biosciences had 5 total employees, including 4 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
5
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,472,200
Market Cap
86.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Exagen | 179 |
OptimizeRx | 136 |
LENSAR | 130 |
Fractyl Health | 102 |
HilleVax | 90 |
Skye Bioscience | 11 |
Coya Therapeutics | 8 |
ANIX News
- 17 days ago - Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 - PRNewsWire
- 4 weeks ago - Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset - PRNewsWire
- 4 weeks ago - Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial - PRNewsWire
- 6 weeks ago - Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting - PRNewsWire
- 6 weeks ago - Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting - PRNewsWire
- 7 weeks ago - Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024 - PRNewsWire
- 7 weeks ago - Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting - PRNewsWire
- 2 months ago - Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial - PRNewsWire